The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling
Abstract
p53 is a well known tumor suppressor. We show that p53 also regulates osteoblast differentiation, bone formation, and osteoblast-dependent osteoclast differentiation. Indeed, p53−/− mice display a high bone mass phenotype, and p53−/− osteoblasts show accelerated differentiation, secondary to an increase in expression of the osteoblast differentiation factor osterix, as a result. Reporter assays indicate that p53 represses osterix transcription by the minimal promoter in a DNA-binding–independent manner. In addition, p53−/− osteoblasts have an enhanced ability to favor osteoclast differentiation, in association with an increase in expression of macrophage-colony stimulating factor, which is under the control of osterix. Furthermore, inactivating p53 is sufficient to rescue the osteoblast differentiation defects observed in mice lacking c-Abl, a p53-interacting protein. Thus, these results identify p53 as a novel regulator of osteoblast differentiation, osteoblast-dependent osteoclastogenesis, and bone remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to these scenarios, p53 can also suppress differentiation, as exemplified by its ability to inhibit osteoblast differentiation and bone development in mice (Lengner et al., 2006; Wang et al., 2006).”
From p53 at a glance (2010) · cites this paper as Wang et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 1×
“It has been well established that osteoblasts control osteoclast differentiation by synthesizing M-CSF, RANKL, and osteoprotegerin (OPG, a RANKL decoy receptor; Suda et al., 1999; Boyle et al., 2003).”
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“The major role of p53 is to promote cell cycle arrest, programmed cell death, and cell senescence, and it is mutated in more than half of the primary human tumors (Ko and Prives, 1996; Vogelstein et al., 2000).”
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Self-citationNakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608 · cited 2×
“One is osterix, which has mainly been studied in a developmental context until this point (Nakashima et al., 2002).”
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Self-citationCanonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Self-citationLeptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311 · cited 1×
“The other is ATF4, which controls both osteoblast differentiation and function (Yang et al., 2004; Elefteriou et al., 2005).”
Self-citationRegulation of the Human hsp70 Promoter by p53
Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292 · cited 1×
“In some cases, the repression is independent of DNA binding (Agoff et al., 1993; Zhai and Comai, 2000; Crighton et al., 2003; Rocha et al., 2003). p53 can be brought to the promoter regions of these genes through other DNA-binding proteins, such as the CAAT-binding factor (Zhai and Comai, 2000),…”
Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53
Zhai, W., & Comai, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5930-5938.2000 · Cited by 289 · cited 2×
“In some cases, the repression is independent of DNA binding (Agoff et al., 1993; Zhai and Comai, 2000; Crighton et al., 2003; Rocha et al., 2003).”
Research works printed but not linked: 40
- 1997, Biochim. Biophys. Acta., 1333, F1
- 2005, Cancer Res., 65, 1124, 10.1158/0008-5472.CAN-04-2128 · DOI
- 2000, Anticancer Res., 20, 2553
- 1999, Cell. Mol. Life Sci., 55, 38, 10.1007/s000180050268 · DOI
- 2003, Cell., 113, 301, 10.1016/S0092-8674(03)00308-8 · DOI · Paper page
- 2003, EMBO J., 22, 2810, 10.1093/emboj/cdg265 · DOI
- 2004, Nat. Genet., 36, 906, 10.1038/ng1396 · DOI
- 1996, Nature., 382, 448, 10.1038/382448a0 · DOI · Paper page
- 2002, Mol. Cell. Biol., 22, 6222, 10.1128/MCB.22.17.6222-6233.2002 · DOI · Paper page
- 1998, Genes Dev., 12, 2973, 10.1101/gad.12.19.2973 · DOI · Paper page
- 2000, Trends Biochem. Sci., 25, 59, 10.1016/S0968-0004(99)01527-3 · DOI · Paper page
- 1997, Curr. Biol., 7, R144, 10.1016/S0960-9822(97)70074-5 · DOI
- 2003, Cell Death Differ., 10, 404, 10.1038/sj.cdd.4401191 · DOI · Paper page
- 2003, Genes Dev., 17, 1309, 10.1101/gad.1099903 · DOI · Paper page
- 1996, Genes Dev., 10, 1054, 10.1101/gad.10.9.1054 · DOI · Paper page
- 2000, Nat. Genet., 24, 304, 10.1038/73542 · DOI · Paper page
- 2004, Genes Dev., 18, 1824, 10.1101/gad.1223504 · DOI
- 1995, N. Engl. J. Med., 332, 305, 10.1056/NEJM199502023320506 · DOI · Paper page
- 1996, Genes Dev., 10, 2971, 10.1101/gad.10.23.2971 · DOI · Paper page
- 1999, Genes Dev., 13, 2490, 10.1101/gad.13.19.2490 · DOI · Paper page
- 1999, J. Biol. Chem., 274, 36031, 10.1074/jbc.274.51.36031 · DOI · Paper page
- 2003, Mol. Cell. Biol., 23, 4713, 10.1128/MCB.23.13.4713-4727.2003 · DOI · Paper page
- 2000, Oncogene., 19, 1834, 10.1038/sj.onc.1203500 · DOI
- 2000, Nat. Med., 6, 985, 10.1038/79683 · DOI · Paper page
- 1995, Nat. Genet., 10, 175, 10.1038/ng0695-175 · DOI · Paper page
- 2002, J. Bone Miner. Res., 17, 119, 10.1359/jbmr.2002.17.1.119 · DOI
- 1996, Blood., 88, 2531, 10.1182/blood.V88.7.2531.bloodjournal8872531 · DOI
- 1999, Mol. Carcinog., 25, 132, 10.1002/(SICI)1098-2744(199906)25:2<132::AID-MC8>3.0.CO;2-2 · DOI
- 2005, Biochem. Biophys. Res. Commun., 331, 834, 10.1016/j.bbrc.2005.03.190 · DOI · Paper page
- 1999, J. Clin. Invest., 104, 503, 10.1172/JCI7094 · DOI · Paper page
- 1999, Endocr. Rev., 20, 345, 10.1210/edrv.20.3.0367 · DOI · Paper page
- 2003, Development., 130, 3929, 10.1242/dev.00615 · DOI
- 1993, J. Clin. Invest., 91, 257, 10.1172/JCI116179 · DOI · Paper page
- 1992, Cancer Res., 52, 6194
- 2003, Hum. Mutat., 21, 313, 10.1002/humu.10185 · DOI · Paper page
- 1998, EMBO J., 17, 4668, 10.1093/emboj/17.16.4668 · DOI · Paper page
- 2001, J. Biol. Chem., 276, 13505, 10.1074/jbc.R000025200 · DOI · Paper page
- 2000, Proc. Natl. Acad. Sci. USA., 97, 5486, 10.1073/pnas.97.10.5486 · DOI
- 2004, Cell., 117, 387, 10.1016/S0092-8674(04)00344-7 · DOI · Paper page
- 1999, Proc. Natl. Acad. Sci. USA., 96, 14517, 10.1073/pnas.96.25.14517 · DOI · Paper page
Cited by
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Stolzing, A., Jones, E., McGonagle, D., & Scutt, A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.002 · Cited by 1,195
Building strong bones: molecular regulation of the osteoblast lineage
Long, F. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3254 · Cited by 1,141
Zhou, S., Greenberger, J. S., Epperly, M. W., Goff, J. P., Adler, C., LeBoff, M. S., & Glowacki, J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00377.x · Cited by 785
Development of the Endochondral Skeleton
Long, F., & Ornitz, D. M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008334 · Cited by 663
Signaling and transcriptional regulation in osteoblast commitment and differentiation
Huang, W. (2007) · Frontiers in Bioscience · doi:10.2741/2296 · Cited by 649
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2716 · Cited by 609
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Bolamperti, S., Villa, I., & Rubinacci, A. (2022) · Bone Research · doi:10.1038/s41413-022-00219-8 · Cited by 482
Networks and hubs for the transcriptional control of osteoblastogenesis
Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., & Young, D. W. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9001-5 · Cited by 468
Brady, C. A., & Attardi, L. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.064501 · Cited by 403
Transcription factors controlling osteoblastogenesis
Marie, P. J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.030 · Cited by 387
Zambetti, N. A., Ping, Z., Chen, S., Kenswil, K. J. G., Mylona, M. A., Sanders, M. A., Hoogenboezem, R. M., Bindels, E. M. J., Adisty, M. N., Van Strien, P. M. H., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.021 · Cited by 342
Genetic and molecular control of osterix in skeletal formation
Sinha, K. M., & Zhou, X. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24439 · Cited by 297
A look behind the scenes: the risk and pathogenesis of primary osteoporosis
Hendrickx, G., Boudin, E., & Van Hul, W. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.48 · Cited by 285
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
Berman, S. D., Calo, E., Landman, A. S., Danielian, P. S., Miller, E. S., West, J. C., Fonhoue, B. D., Caron, A., Bronson, R., Bouxsein, M. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805462105 · Cited by 266
Regulation and Role of Transcription Factors in Osteogenesis
Chan, W. C. W., Tan, Z., To, M. K. T., & Chan, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115445 · Cited by 261
Mechanotransduction in osteoblast regulation and bone disease
Papachroni, K. K., Karatzas, D. N., Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.03.001 · Cited by 252
Blaber, E. A., Dvorochkin, N., Lee, C., Alwood, J. S., Yousuf, R., Pianetta, P., Globus, R. K., Burns, B. P., & Almeida, E. A. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061372 · Cited by 196
“Furthermore, p53 knockout mice have preserved trabecular bone volume following hindlimb-unloading [28] and generally, osteopetrotic bone, suggesting a role for the p53-signaling pathway in the regulation of bone formation and degradation [29,30].”
BackgroundInfluentialDNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age
Kim, H., Chang, J., Shao, L., Han, L., Iyer, S., Manolagas, S. C., O'Brien, C. A., Jilka, R. L., Zhou, D., & Almeida, M. (2017) · Aging Cell · doi:10.1111/acel.12597 · Cited by 192
“Studies using p53 / mice, or mice with osteoblast specific p53 gain- or loss-offunction have provided compelling evidence that p53 inhibits osteoblastogenesis (Lengner et al., 2006; Wang et al., 2006).”
BackgroundCell Death in Chondrocytes, Osteoblasts, and Osteocytes
Komori, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122045 · Cited by 176
“The introduction of p53 into wild-type and p53−/− osteoblasts inhibits osteoblast differentiation [90].”
BackgroundResultOsteosarcoma: Molecular Pathogenesis and iPSC Modeling
Lin, Y.-H., Jewell, B. E., Gingold, J., Lu, L., Zhao, R., Wang, L. L., & Lee, D.-F. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.06.004 · Cited by 150
“While p53 is traditionally thought to primarily promote cellular differentiation, studies on the role of p53 in bone development suggest that p53 might play a negative regulatory role by attenuating osteoblast differentiation [26,27].”
BackgroundTaylor, S., Ominsky, M. S., Hu, R., Pacheco, E., He, Y. D., Brown, D. L., Aguirre, J. I., Wronski, T. J., Buntich, S., Afshari, C. A., et al. (2016) · Bone · doi:10.1016/j.bone.2015.12.013 · Cited by 106
Kim, B.-S., Kim, S.-J., Kim, H.-J., Lee, S.-J., Park, Y.-J., Lee, J., & You, H.-K. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.10.019 · Cited by 98
Wang, H., Chen, Q., Lee, S., Choi, Y., Brad Johnson, F., & Pignolo, R. J. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00838.x · Cited by 81
DNA damage in aging, the stem cell perspective
McNeely, T., Leone, M., Yanai, H., & Beerman, I. (2020) · Human Genetics · doi:10.1007/s00439-019-02047-z · Cited by 52
Metadata
- Authors
- Wang, X., Kua, H.-Y., Hu, Y., Guo, K., Zeng, Q., Wu, Q., Ng, H.-H., Karsenty, G., de Crombrugghe, B., Yeh, J., & Li, B.
- Affiliations
- 1The Institute of Molecular and Cell Biology, Singapore 138673
- 2Laboratory of Cell and Medical Biology, Genome Institute of Singapore, Singapore 138672
- 3Department of Molecular and Human Genetics and Bone Disease Program of Texas, Baylor College of Medicine, Houston, TX 77030
- 4Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030
- 5Department of Medicine, Winthrop-University Hospital, Mineola, NY 11501
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2005-12-27
- Volume
- 172
- Issue
- 1
- Pages
- 115-125
- ISSN
- 1540-8140
- 0021-9525
- Cited by
- 225
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.